LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
Will AstraZeneca be the next FTSE 100 stock to move to the US?
Investing Articles
5 top FTSE 100 stocks offering plenty of global growth for an ISA
Investing Articles
At a bargain-basement valuation now, is AstraZeneca’s share price impossible for me to ignore?
Investing Articles
These 5 UK shares could supercharge investors’ pension savings by 21.7% in just 1 year
Investing Articles
FTSE 100 shares to consider buying for a well balanced Stocks and Shares ISA
Investing Articles
I asked ChatGPT for the best UK shares to buy now — its top pick surprised me…
Investing Articles
I’m throwing every penny at today’s stock market recovery – I think it has further to run
Investing Articles
21 analysts advised buy AstraZeneca shares in January – see what £10k invested then is worth now
Investing Articles
Why did the AstraZeneca share price just fall, and what should we do?
Investing Articles
3 UK shares the pros are buying right now!
Investing Articles
Does the GSK or AstraZeneca share price currently offer the best value?